Hospice Compare Website Running Into Problems
There has been interesting news over the past several months regarding CMS’ Hospice Compare website. As reported by Modern…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
June 2018
FDA Final Guidance: Drug and Device Manufacturer Communications with…
FDA recently announced the availability of an important guidance for industry. The document, “Drug and Device Manufacturer…
Former Valeant Executive Found Guilty of Anti-Kickback Violations
Valeant Pharmaceuticals, Inc. has had a bumpy three years due to allegations of executive bribes and mismanagement. The most…
AstraZeneca to Reveal HCP Payments Worldwide
Earlier this month, pharmaceutical powerhouse AstraZeneca announced that it would disclose all payments to healthcare providers in…
FDA Proposes Reorganizing CDER Office of New Drugs
On June 4, the Food and Drug Administration (FDA) released additional information regarding the proposal to modernize the Center…
Rockpointe and AudioEducate Launch First Ever Accredited CME Program on…
“Alexa, let me hear all about the ethical principles involved in human experimentation.”
Rockpointe launches the first…
Vermont Passes Manufacturer and Insurer Pharmaceutical Cost Transparency…
On May 30th, Vermont Governor Phil Scott (R) signed Senate Bill 92 into law (now, Act 193). A law that adds new reporting…
Senator McCaskill Introduces: The Patient Advocacy Transparency Act of 2018
As a follow-up to Senator Claire McCaskill’s long running opioid investigation and report titled: Fueling an Epidemic: Exposing…
FDA Announces Pilot Program for Orphan Drug Submissions
The FDA had more than 700 orphan drug designation requests last year. As a result, the FDA recently announced a new pilot program…
Connecticut’s New Drug Pricing Law Requires Transparency from PBMs, Health…
On May 31st, Connecticut’s governor Daniel Malloy signed into law Substitute House Bill 5384, which imposes cost disclosure and…